Point72 (Difc) LTD Ultragenyx Pharmaceutical Inc. Transaction History
Point72 (Difc) LTD
- $2.44 Trillion
- Q1 2025
A detailed history of Point72 (Difc) LTD transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 21,445 shares of RARE stock, worth $602,818. This represents 0.03% of its overall portfolio holdings.
Number of Shares
21,445
Previous 18,620
15.17%
Holding current value
$602,818
Previous $783 Million
0.87%
% of portfolio
0.03%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding RARE
# of Institutions
330Shares Held
89.3MCall Options Held
1.05MPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA10.2MShares$287 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$158 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$117 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$90.5 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$73.6 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $1.97B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...